MKD*
Epidemiology | |||
---|---|---|---|
Gender ratio |
1 : 1 |
Prevalence |
>300 cases |
Disease presentation
Genetic grounds
The disease shows an autosomal recessive inheritance (i.e., each parent must give a mutated gene for a child to develop the disease). The involved mutated gene is MVK coding for mevalonate kinase involved in cholesterol synthesis.Main clinical symptoms
Elevated fever with chills
Abdominal pain
Mouth ulcers
Biological signs
Increase of C-reactive protein (CRP)
Decrease of mevalonate
Therapy
- Anti-IL-1 (e.g. Anakinra, Canakinumab)
- Corticosteroids
- Anti-IL-6 (e.g. Tocitizumab)
*Mevalonate Kinase Disease, also known as Hyper-IgD syndrome (HIDS)